Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Periop-01: A randomized controlled trial of extended perioperative tinzaparin to improve disease-free survival in patients with resectable colorectal cancer.
Authors
Rebecca Ann C Auer
Ottawa Hospital Research Institute, University Of Ottawa, Ottawa, ON, Canada
Rebecca Ann C Auer , Paul Jack Karanicolas , Michael Ott , Muriel Brackstone , Shady Ashamalla , Timothy R. Asmis , Marylise Boutros , Antonio Caycedo Marulanda , Shiva Jayaraman , Derek J. Jonker , Husein Moloo , Sunil Patel , Silvana Spadafora , Steven MacLellan , Ranjeeta Mallick , Peter Stotland , Vicky Tagalakis , Daniel C. Trottier , Joel Weaver , Marc Carrier
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT01455831
DOI
10.1200/JCO.2022.40.4_suppl.124
Abstract #
124
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling prognosis and traits of dMMR/MSI-H gastric and colorectal cancer after curative surgery: A large-scale, multi-center, retrospective study in China.
First Author: Ting Deng
Poster
2023 ASCO Annual Meeting
Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) randomized clinical trials (RCTs).
First Author: Davide Soldato
Poster
2022 ASCO Genitourinary Cancers Symposium
Quantifying absolute benefit of adjuvant treatments in renal cell carcinoma: A systematic review and network-meta-analysis.
First Author: Qurat Ul Ain Riaz Sipra
Poster
2021 Genitourinary Cancers Symposium
A retrospective real-world major bleeding (MB) comparison of direct oral anticoagulants (DOAC) and low molecular weight heparin (LMWH) in genitourinary cancer-associated venous thromboembolism (GU-CAVTE) with reported randomized clinical trials (RTC).
First Author: Ulyana Dashkevych